Your browser doesn't support javascript.
loading
Intravascular Lithotripsy: Approach to Advanced Calcified Coronary Artery Lesions, Current Understanding, and What Could Possibly Be Studied Next.
Kochiashvili, Giorgi; Fongrat, Natalia; Baraskar, Bhavana; Amare, Biruk; Iantorno, Micaela.
Afiliación
  • Kochiashvili G; Internal Medicine, Mary Washington Healthcare, Fredericksburg, VA 22401, USA.
  • Fongrat N; Internal Medicine, Mary Washington Healthcare, Fredericksburg, VA 22401, USA.
  • Baraskar B; Internal Medicine, Mary Washington Healthcare, Fredericksburg, VA 22401, USA.
  • Amare B; Internal Medicine, Mary Washington Healthcare, Fredericksburg, VA 22401, USA.
  • Iantorno M; Oracle Heart & Vascular, Fredericksburg, VA 22401, USA.
J Clin Med ; 13(16)2024 Aug 20.
Article en En | MEDLINE | ID: mdl-39201049
ABSTRACT
Calcified and resistant narrowing of arteries poses significant difficulty in performing percutaneous coronary interventions (PCIs), as they increase the risk of subpar outcomes leading to worse clinical outcomes. Despite the existence of dedicated technologies and devices, including various balloons and atherectomy systems, they often do not ensure sufficient plaque modification and ideal vessel preparation for optimal stent deployment. Intravascular lithotripsy (IVL), a technology originally developed for urological procedures, has recently been used to safely and selectively disrupt calcified depositions in both peripheral and coronary arteries by sonic waves that seamlessly transfer to nearby tissue, enhancing vessel compliance with minimal impact on soft tissues. In the coronary arteries, the use of IVL plays a role in the process of "vessel preparation" before the placement of stents, which is crucial for restoring blood flow in patients with severe coronary artery disease (CAD), and is considered a minimally invasive technique, reducing the need for open heart surgeries and associated risks and complications. Studies have shown that IVL can lead to improved procedural success rates and favorable long-term outcomes for patients with severely calcified coronary artery disease. With the advent of IVL, the disruption of severe calcification of coronary artery and stenotic lesions before stent implantations can be performed. Despite promising data for treating calcified lesions, IVL is significantly underutilized in clinical practice, long-term clinical data and extensive research are needed to validate its further safety and efficacy. In this article, we reviewed the literature discussing the use of IVL in the coronary arteries as an approach for addressing intravascular atherosclerotic plaques, particularly focusing on heavily calcified plaques that are resistant to standard initial PCI, while also evaluating its safety in comparison to alternative methods.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: J Clin Med Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: J Clin Med Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos